PortfoliosLab logoPortfoliosLab logo
VTRS vs. BHC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VTRS vs. BHC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Viatris Inc. (VTRS) and Bausch Health Companies Inc. (BHC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VTRS achieves a 43.29% return, which is significantly higher than BHC's -0.86% return.


VTRS

1D
-1.13%
1M
5.15%
6M
36.29%
YTD
43.29%
1Y
107.17%
3Y*
25.05%
5Y*
9.02%
10Y*
ALL TIME*
6.02%

BHC

1D
14.26%
1M
40.61%
6M
20.03%
YTD
-0.86%
1Y
20.67%
3Y*
-10.06%
5Y*
-25.11%
10Y*
-10.62%
ALL TIME*
-4.87%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$34.14M$20.89M$15.02M
$169.50M$158.94M$180.27M

VTRS vs. BHC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
VTRS
Viatris Inc.
43.29%5.08%19.68%2.06%-14.29%-26.12%19.82%
BHC
Bausch Health Companies Inc.
-0.86%-13.77%0.50%27.71%-77.25%32.74%6.12%

Correlation

The correlation between VTRS and BHC is 0.30, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.30

Correlation (3Y)
Balances recent behavior with more history.

0.32

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.38

Correlation (All Time)
Calculated using the full available price history since Nov 16, 2020

0.37

Fundamentals

Market Cap

VTRS:

$20.45B

BHC:

$2.57B

EPS

VTRS:

-$0.25

BHC:

-$3.87

PS Ratio

VTRS:

1.40

BHC:

0.18

Total Revenue (TTM)

VTRS:

$14.56B

BHC:

$10.80B

Gross Profit (TTM)

VTRS:

$5.01B

BHC:

$7.78B

EBITDA (TTM)

VTRS:

$1.89B

BHC:

$1.78B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VTRS vs. BHC — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

VTRS
VTRS Risk / Return Rank: 9797
Overall Rank
VTRS Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
VTRS Sortino Ratio Rank: 9898
Sortino Ratio Rank
VTRS Omega Ratio Rank: 9797
Omega Ratio Rank
VTRS Calmar Ratio Rank: 9696
Calmar Ratio Rank
VTRS Martin Ratio Rank: 9696
Martin Ratio Rank

BHC
BHC Risk / Return Rank: 5656
Overall Rank
BHC Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
BHC Sortino Ratio Rank: 5959
Sortino Ratio Rank
BHC Omega Ratio Rank: 5656
Omega Ratio Rank
BHC Calmar Ratio Rank: 5555
Calmar Ratio Rank
BHC Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

VTRS vs. BHC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Viatris Inc. (VTRS) and Bausch Health Companies Inc. (BHC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VTRSBHCDifference
Sharpe ratioReturn per unit of total volatility

+3.09

Sortino ratioReturn per unit of downside risk

+3.36

Omega ratioGain probability vs. loss probability

1.55

1.11

+0.44

Calmar ratioReturn relative to maximum drawdown

5.77

0.36

+5.41

Martin ratioReturn relative to average drawdown

16.02

0.59

+15.43

VTRS vs. BHC - Sharpe Ratio Comparison

The current VTRS Sharpe Ratio is 3.38, which is higher than the BHC Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of VTRS and BHC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VTRS vs. BHC - Drawdown Comparison

The maximum VTRS drawdown since its inception was -54.33%, smaller than the maximum BHC drawdown of -98.35%. Use the drawdown chart below to compare losses from any high point for VTRS and BHC.


Loading charts...

Drawdown Indicators


VTRSBHCDifference

Max Drawdown

Largest peak-to-trough decline

-54.33%

-98.35%

+44.02%

Max Drawdown (1Y)

Largest decline over 1 year

-18.97%

-46.88%

+27.91%

Max Drawdown (3Y)

Largest decline over 3 years

-45.02%

-59.28%

+14.26%

Max Drawdown (5Y)

Largest decline over 5 years

-45.69%

-85.34%

+39.65%

Max Drawdown (10Y)

Largest decline over 10 years

-87.43%

Current Drawdown

Current decline from peak

-1.68%

-97.38%

+95.70%

Average Drawdown

Average peak-to-trough decline

-30.13%

-61.09%

+30.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.82%

28.88%

-22.06%

Volatility

VTRS vs. BHC - Volatility Comparison

The current volatility for Viatris Inc. (VTRS) is 8.74%, while Bausch Health Companies Inc. (BHC) has a volatility of 29.65%. This indicates that VTRS experiences smaller price fluctuations and is considered to be less risky than BHC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VTRSBHCDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.74%

29.65%

-20.91%

Volatility (6M)

Calculated over the trailing 6-month period

24.26%

41.03%

-16.77%

Volatility (1Y)

Calculated over the trailing 1-year period

32.52%

58.81%

-26.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

33.45%

62.52%

-29.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.80%

60.32%

-26.52%

Dividends

VTRS vs. BHC - Dividend Comparison

VTRS's dividend yield for the trailing twelve months is around 2.73%, while BHC has not paid dividends to shareholders.


PositionTTM20252024202320222021
BHC
Bausch Health Companies Inc.
0.00%0.00%0.00%0.00%0.00%0.00%
VTRS
Viatris Inc.
2.73%3.86%3.86%4.43%4.31%2.44%

Financials

VTRS vs. BHC - Financials Comparison

This section allows you to compare key financial metrics between Viatris Inc. and Bausch Health Companies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

VTRS vs. BHC - Profitability Comparison

The chart below illustrates the profitability comparison between Viatris Inc. and Bausch Health Companies Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

VTRS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Viatris Inc. reported a gross profit of 1.16B and revenue of 3.52B. Therefore, the gross margin over that period was 32.9%.

BHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Bausch Health Companies Inc. reported a gross profit of 2.81B and revenue of 2.83B. Therefore, the gross margin over that period was 99.3%.

VTRS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Viatris Inc. reported an operating income of -79.70M and revenue of 3.52B, resulting in an operating margin of -2.3%.

BHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Bausch Health Companies Inc. reported an operating income of 740.00M and revenue of 2.83B, resulting in an operating margin of 26.2%.

VTRS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Viatris Inc. reported a net income of 176.40M and revenue of 3.52B, resulting in a net margin of 5.0%.

BHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Bausch Health Companies Inc. reported a net income of 258.00M and revenue of 2.83B, resulting in a net margin of 9.1%.


Frequently Asked Questions


VTRS and BHC have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BHC has higher volatility (29.65%) compared to VTRS (8.74%). In terms of maximum drawdown, VTRS dropped -54.33% vs BHC's -98.35%.

VTRS currently has the higher Sharpe Ratio (3.38 vs 0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VTRS and BHC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer